Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7113
Gene Symbol: TMPRSS2
TMPRSS2 		0.010 AlteredExpression disease BEFREE Immunohistochemical evaluation of TMPRSS2-ERG gene fusion in adenosis of the prostate. 23664537 2013
Entrez Id: 2078
Gene Symbol: ERG
ERG 		0.010 AlteredExpression disease BEFREE None (0%) of the foci of adenosis were positive for ERG protein expression. 23664537 2013
Entrez Id: 107075310
Gene Symbol: MTCO2P12
MTCO2P12 		0.010 AlteredExpression disease BEFREE In nulliparous female mice, aberrant COX-2 overexpression correlated with increased prostaglandin (PG) E(2) levels and caused cystic duct dilatations, adenosis, and fibrosis whereas carcinomas developed rarely. 15681840 2005
Entrez Id: 4513
Gene Symbol: COX2
COX2 		0.010 AlteredExpression disease BEFREE In nulliparous female mice, aberrant COX-2 overexpression correlated with increased prostaglandin (PG) E(2) levels and caused cystic duct dilatations, adenosis, and fibrosis whereas carcinomas developed rarely. 15681840 2005
Entrez Id: 5743
Gene Symbol: PTGS2
PTGS2 		0.010 AlteredExpression disease BEFREE In nulliparous female mice, aberrant COX-2 overexpression correlated with increased prostaglandin (PG) E(2) levels and caused cystic duct dilatations, adenosis, and fibrosis whereas carcinomas developed rarely. 15681840 2005
Entrez Id: 4610
Gene Symbol: MYCL
MYCL 		0.010 GeneticVariation disease BEFREE Loss of heterozygosity/allelic imbalance was detected in six of 17 cases of apocrine adenosis; three of 12 (25%) informative cases at 1p (MYCL1), two of seven (28.6%) at 11q (INT2), one of three (33.3%) at 13q (D13S267), two of 12 (16.7%) at 16q (D16S539), and two of 10 (20%) at 17q (D17S250). 11425268 2001
Entrez Id: 2248
Gene Symbol: FGF3
FGF3 		0.010 GeneticVariation disease BEFREE Loss of heterozygosity/allelic imbalance was detected in six of 17 cases of apocrine adenosis; three of 12 (25%) informative cases at 1p (MYCL1), two of seven (28.6%) at 11q (INT2), one of three (33.3%) at 13q (D13S267), two of 12 (16.7%) at 16q (D16S539), and two of 10 (20%) at 17q (D17S250). 11425268 2001
Entrez Id: 57508
Gene Symbol: INTS2
INTS2 		0.010 GeneticVariation disease BEFREE Loss of heterozygosity/allelic imbalance was detected in six of 17 cases of apocrine adenosis; three of 12 (25%) informative cases at 1p (MYCL1), two of seven (28.6%) at 11q (INT2), one of three (33.3%) at 13q (D13S267), two of 12 (16.7%) at 16q (D16S539), and two of 10 (20%) at 17q (D17S250). 11425268 2001